Airing weekdays at 7:30 A.M. on

Airing weekdays at 7:30 A.M. on

The Balancing Act goes Behind the Mystery of Pulmonary Arterial Hypertension (PAH).

PAH can eventually lead to heart failure, and ultimately, death, but treatment may delay the disease from getting worse, which is why awareness for this rare disease is so important.

The Balancing Act host Olga Villaverde sits down with pulmonologist Dr. Lana Melendres-Groves and Marla, a patient with PAH, to learn more about the disease and its effects on patients.

Due to the progressive nature of PAH, it’s vital that patients stay vigilant with how they are feeling and to communicate with their physician; and for doctors to continue to assess a patient’s risk for disease progression.

Management of PAH may include lifestyle changes and adding additional therapies to a treatment regimen. It’s important to stay ahead of the disease; even if symptoms don’t seem to be getting worse, always talk to your doctor to make sure your treatment plan is still right for you.

Knowing the risk of being an OTC carrier and how to prepare for it with the UCD Genetic Testing Program, sponsored by Horizon Therapeutics and performed by Invitae.

Acromegaly is a slow-progressing disorder that occurs when the pituitary gland produces too much growth hormone.

Up next, stay tuned for a brand-new Behind the Mystery special — only on The Balancing Act.

Comments

comments